Conestoga Capital Advisors, LLC Vericel Corp Transaction History
Conestoga Capital Advisors, LLC
- $6.58 Billion
- Q2 2024
A detailed history of Conestoga Capital Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 2,041,370 shares of VCEL stock, worth $92.3 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
2,041,370
Previous 2,331,310
12.44%
Holding current value
$92.3 Million
Previous $121 Million
22.77%
% of portfolio
1.42%
Previous 1.77%
Shares
20 transactions
Others Institutions Holding VCEL
# of Institutions
268Shares Held
48.4MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$364 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$200 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$156 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$112 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.8MShares$81.4 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.13B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...